A proteogenomic surfaceome study identifies DLK1 as an immunotherapeutic target in neuroblastoma.
蛋白质基因组表面组学研究发现 DLK1 是神经母细胞瘤的免疫治疗靶点
期刊:Cancer Cell
影响因子:44.5
doi:10.1016/j.ccell.2024.10.003
Hamilton Amber K, Radaoui Alexander B, Tsang Matthew, Martinez Daniel, Conkrite Karina L, Patel Khushbu, Sidoli Simone, Delaidelli Alberto, Modi Apexa, Rokita Jo Lynne, Lane Maria V, Hartnett Nicholas, Lopez Raphael D, Zhang Bo, Zhong Chuwei, Ennis Brian, Miller Daniel P, Brown Miguel A, Rathi Komal S, Raman Pichai, Pogoriler Jennifer, Bhatti Tricia, Pawel Bruce, Glisovic-Aplenc Tina, Teicher Beverly, Erickson Stephen W, Earley Eric J, Bosse Kristopher R, Sorensen Poul H, Krytska Kateryna, Mosse Yael P, Havenith Karin E, Zammarchi Francesca, van Berkel Patrick H, Smith Malcolm A, Garcia Benjamin A, Maris John M, Diskin Sharon J
